• Stabilization period for the global offering ended Aug. 1, 2026; no over-allotment option exercise, option lapsed.
• Stabilizing manager over-allocated 5,407,500 H shares in the international offering, about 5% of initial offer shares.
• Successive market purchases totaled 5,407,500 H shares at HK$ 2.69–HK$ 4.76; last buy July 31 at HK$ 2.79.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beijing Tong Ren Tang Healthcare Investment Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260803-12267142), on August 03, 2026, and is solely responsible for the information contained therein.